US Bancorp DE Has $21.04 Million Stock Position in The Clorox Company (NYSE:CLX)

US Bancorp DE reduced its stake in The Clorox Company (NYSE:CLX - Free Report) by 3.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 129,134 shares of the company's stock after selling 5,042 shares during the period. US Bancorp DE owned 0.10% of Clorox worth $21,037,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Clorox by 0.3% in the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 326,479 shares of the company's stock valued at $49,987,000 after acquiring an additional 923 shares during the last quarter. Diversify Advisory Services LLC acquired a new position in shares of Clorox in the first quarter valued at approximately $356,000. Mirae Asset Global Investments Co. Ltd. increased its position in shares of Clorox by 99.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,813 shares of the company's stock worth $7,136,000 after acquiring an additional 22,882 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. raised its holdings in shares of Clorox by 18.3% during the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 3,748 shares of the company's stock worth $574,000 after acquiring an additional 581 shares during the period. Finally, Fidelis Capital Partners LLC bought a new stake in Clorox in the 1st quarter valued at $63,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on CLX shares. Deutsche Bank Aktiengesellschaft raised their price objective on Clorox from $144.00 to $151.00 and gave the company a "hold" rating in a report on Friday, August 2nd. DA Davidson reiterated a "neutral" rating and issued a $153.00 price objective on shares of Clorox in a research note on Friday, September 6th. BNP Paribas upgraded shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. Barclays raised their target price on shares of Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a report on Friday. Finally, Citigroup increased their price target on Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Six equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Clorox presently has an average rating of "Hold" and an average target price of $150.29.

Insider Transactions at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of the business's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company's stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Trading Up 2.9 %

NYSE CLX traded up $4.56 on Friday, reaching $163.11. The company had a trading volume of 2,296,113 shares, compared to its average volume of 1,243,288. The firm has a market cap of $20.20 billion, a price-to-earnings ratio of 56.83, a P/E/G ratio of 3.12 and a beta of 0.41. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The Clorox Company has a fifty-two week low of $121.76 and a fifty-two week high of $169.09. The business has a 50 day moving average of $161.48 and a two-hundred day moving average of $146.17.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a return on equity of 292.08% and a net margin of 4.78%. The business's quarterly revenue was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.49 earnings per share. Analysts forecast that The Clorox Company will post 6.64 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. The ex-dividend date is Wednesday, October 23rd. Clorox's dividend payout ratio is currently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.